Ligand ID: 0RN Drugbank ID: DB09324(Sulbactam) Indication:Sulbactam is currently available in combination products with ampicillin. Within this formulation it is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) | 2g9t | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 10 | TYR F 76ASN F 85VAL F 108GLY F 70ALA F 71 | 1.52A | 20.78 | None | ||
![]() | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 10 | CYH C 265TYR A 209THR C 224ALA C 267ARG A 222 | 1.77A | 22.64 | None | ||
![]() | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 10 | CYH A 473SER A 470ASN A 478ALA A 488ARG A 492 | 1.70A | 19.19 | None | ||
![]() | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | TYR B 660SER B 673VAL B 675GLY B 638ALA B 595 | 1.63A | 12.50 | None | ||
![]() | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 10 | TYR A 292SER A 288VAL A 441GLY A 102ARG A 98 | 1.62A | 18.33 | None |